Arthritis Research & Therapy

official impact factor 4.36

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis

Hani S El-Gabalawy* and John A Wilkins

Arthritis Res Ther 2004, 6:86-89 doi:10.1186/ar1171

Accesses  

  • Last 30 days: 33 accesses
  • Last 365 days: 454 accesses
  • All time: 2729 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis

Christian Dejaco, Werner Klotz, Heike Larcher, Christina Duftner, Michael Schirmer, Manfred Herold Arthritis Research & Therapy 2006, 8:R119 (19 July 2006)